The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis

  1. Dug Keun Lee,
  2. Seok Hee Park,
  3. Youngsuk Yi,
  4. Shin-Geon Choi3,
  5. Cecile Lee,
  6. W. Tony Parks,
  7. HyeSeong Cho1,
  8. Mark P. de Caestecker,
  9. Yosef Shaul2,
  10. Anita B. Roberts, and
  11. Seong-Jin Kim4
  1. Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892-5055, USA, 1Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon 442-721, Korea; 2The Weizmann Institute of Science, Rehovot 76100, Israel

Abstract

Hepatitis B, one of the most common infectious diseases in the world, is closely associated with acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Many clinical investigations have revealed that hepatic fibrosis is an important component of these liver diseases caused by chronic hepatitis B. TGF-β signaling plays an important role in the pathogenesis of fibrosis in chronic hepatitis and cirrhosis. As these diseases are associated with hepatitis B virus (HBV) infection, we examined the possibility that the HBV-encoded pX oncoprotein regulates TGF-β signaling. We show that pX enhances transcriptional activity in response to TGF-β, BMP-2, and activin by stabilizing the complex of Smad4 with components of the basic transcriptional machinery. Additionally, confocal microscopic studies suggest that pX facilitates and potentiates the nuclear translocation of Smads, further enhancing TGF-β signaling. Our studies suggest a new paradigm for amplification of Smad-mediated signaling by an oncoprotein and suggest that enhanced Smad-mediated signaling may contribute to HBV-associated liver fibrosis.

Keywords

Footnotes

  • 3 Present address: Kangwon National University, 200-701 ChunCheon, Korea.

  • 4 Corresponding author.

  • E-MAIL kims{at}dce41.nci.nih.gov; FAX (301) 496-8395.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.856201.

    • Received October 3, 2000.
    • Accepted December 27, 2000.
| Table of Contents

Life Science Alliance